FIA
LNAI

FNY Investment Advisers’s Lunai Bioworks LNAI Stock Holding History

FNY Investment Advisers’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13
Closed -$4K – 1117
2019
Q2 		$4K Buy
+13
New +$6.34K ﹤0.01% 746

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $535M AUM 19.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FNY Investment Advisers's LNAI Position: Q3 2019 in Review

FNY Investment Advisers sold out of Lunai Bioworks (LNAI) in Q3 2019, closing a stake of 13 shares — an estimated $4K sold.

FNY Investment Advisers first reported a position in LNAI in Q2 2019 and held it in 1 quarter. The position peaked at $4K in Q2 2019. 29 funds tracked by Wall St. Rank hold LNAI as of Q3 2019.

  • FNY Investment Advisers reported no remaining Lunai Bioworks position as of Q3 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 13 Lunai Bioworks shares in Q3 2019, an estimated $4K.
  • FNY Investment Advisers first reported a position in Lunai Bioworks in Q2 2019 and held it in 1 quarter.
  • FNY Investment Advisers's Lunai Bioworks position peaked at $4K in Q2 2019.
  • 29 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2019.

Based on FNY Investment Advisers's 13F filing for Q3 2019, filed 25 Oct 2019.